- Home
- GNLX vs SENS Comparison
GNLX vs SENS Comparison
Compare GNLX & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- SENS
- Stock Information
- Founded
- GNLX 2001
- SENS 1996
- Country
- GNLX United States
- SENS United States
- Employees
- GNLX N/A
- SENS N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- SENS Industrial Machinery/Components
- Sector
- GNLX Health Care
- SENS Industrials
- Exchange
- GNLX Nasdaq
- SENS Nasdaq
- Market Cap
- GNLX 128.0M
- SENS 357.2M
- IPO Year
- GNLX 2023
- SENS N/A
- Fundamental
- Price
- GNLX $4.17
- SENS $0.45
- Analyst Decision
- GNLX Strong Buy
- SENS Strong Buy
- Analyst Count
- GNLX 4
- SENS 5
- Target Price
- GNLX $17.75
- SENS $1.63
- AVG Volume (30 Days)
- GNLX 147.7K
- SENS 5.1M
- Earning Date
- GNLX 11-13-2025
- SENS 11-06-2025
- Dividend Yield
- GNLX N/A
- SENS N/A
- EPS Growth
- GNLX N/A
- SENS N/A
- EPS
- GNLX N/A
- SENS N/A
- Revenue
- GNLX N/A
- SENS $25,466,000.00
- Revenue This Year
- GNLX N/A
- SENS $63.52
- Revenue Next Year
- GNLX N/A
- SENS $67.91
- P/E Ratio
- GNLX N/A
- SENS N/A
- Revenue Growth
- GNLX N/A
- SENS 5.94
- 52 Week Low
- GNLX $1.95
- SENS $0.25
- 52 Week High
- GNLX $5.89
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- GNLX 67.84
- SENS 42.84
- Support Level
- GNLX $3.76
- SENS $0.44
- Resistance Level
- GNLX $3.61
- SENS $0.47
- Average True Range (ATR)
- GNLX 0.24
- SENS 0.02
- MACD
- GNLX 0.06
- SENS 0.00
- Stochastic Oscillator
- GNLX 93.41
- SENS 18.62
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.